Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| N-succinylglycine | C6H7NO4 | 5626-41-5 | Details |
| 25-Desacetyl RifaMpicin | C41H56N4O11 | 16783-99-6 | Details |
| 25-Deacetyl-23-acetyl RifaMpicin | C43H58N4O12 | 1416773-23-3 | Details |
| Benzocaine | C9H11NO2 | 94-09-7 | Details |
| (R)-Naproxen | C14H14O3 | 23979-41-1 | Details |
| (2S,3S)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol | C12H13F2N3O2 | 135270-05-2 | Details |
| 6-METHOXY-2-NAPHTHOIC ACID | C12H10O3 | 2471-70-7 | Details |
| (2'R)-N-Benzoyl-2'-deoxy-2'-fluoro-2'-methylcytidine 3',5'-dibenzoate | C31H26FN3O7 | 817204-32-3 | Details |
| 1,2,4-Triazole sodium | C2H4N3Na | 41253-21-8 | Details |
| 4-Nitrophenylacetic acid | C8H7NO4 | 104-03-0 | Details |
| 2,6-Dichlorobenzoic acid | C7H4Cl2O2 | 50-30-6 | Details |
| (3R,4R,5S)-ethyl 4-acetamido-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate | C22H36N2O4 | 651324-09-3 | Details |
| Isonicotinic acid | C6H5NO2 | 55-22-1 | Details |
| N,N-DiethylisonicotinaMide | C10H14N2O | 530-40-5 | Details |
| N,N-diethylpyridine-3-carboxamide 1-oxide | C10H14N2O2 | 20165-96-2 | Details |
| Benzaldehyde, 3,5-dibromo-2-nitro- | C7H3Br2NO3 | 861787-48-6 | Details |
| NA | Details |
| NA | Details |
| Erythromycin A Enol Ether | C37H65NO12 | 33396-29-1 | Details |
| ethyl 2, 2,4-trichloro-3- oxobutyrate | C6H7Cl3O3 | 85153-67-9 | Details |
| rel-(4aR,7aR)-6-Benzyloctahydro-1H-pyrrolo[3,4-b]pyridine | C14H20N2 | 161594-54-3 | Details |
| TROXACITABINE | C8H11N3O4 | 145918-75-8 | Details |
| 3-CHLOROBENZAL CHLORIDE | C7H5Cl3 | 15145-69-4 | Details |
| PUGODPXGSGWWOT-ZDUSSCGKSA-N | C14H9ClF3NO2 | 2125704-30-3 | Details |
| Enantiomer Efavirenz | C14H9ClF3NO2 | 154801-74-8 | Details |
| Efavirenz Related Compound B (15 mg) ((S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | C14H11ClF3NO2 | 440124-96-9 | Details |
| Efavirenz IP Impurity A | C21H17ClF3NO3 | 353270-77-6 | Details |
| [4-Chloro-2-[(1S)-3-cyclopropyl-1-hydroxy-1-(trifluoromethyl)-2-propynyl)phenyl]carbamic Acid Methyl Ester | C15H13ClF3NO3 | 211563-40-5 | Details |
| Efavirenz | C14H9ClF3NO2 | 154598-52-4 | Details |
| (S)-2-(2-AMINO-5-CHLOROPHENYL)-4-CYCLOPROPYL-1,1,1-TRIFLUOROBUT-3-YN-2-OL | 154598-58-0 | Details |
| Acetamide, N-?[4-?[5-?(acetylamino)?-?2-?hydroxyphenoxy]?phenyl]?- | C16H16N2O4 | 2575516-61-7 | Details |
| Fosfomycin Trometamol EP Impurity A | C3H9O5P | 84954-80-3 | Details |
| 2-Picolinic acid | C6H5NO2 | 98-98-6 | Details |
| N-EthylnicotinaMide | C8H10N2O | 4314-66-3 | Details |
| 3-(ethylcarbamoyl)pyridine 1-oxide | C8H10N2O2 | 68254-63-7 | Details |
| N,N-Diethylpicolinamide | C10H14N2O | 7606-13-5 | Details |
| Tachysterol3 | C27H44O | 17592-07-3 | Details |
| Lecithin Hydrogenated | C42H84NO8P | 92128-87-5 | Details |
| 4-(2-fluoro-4-nitrophenyl) Moropholine | C10H11FN2O3 | 2689-39-6 | Details |
| Methyl picolinate | C7H7NO2 | 2459-07-6 | Details |
| 3,4-Difluoronitrobenzene | C6H3F2NO2 | 369-34-6 | Details |
| Ethyl nicotinate | C8H9NO2 | 614-18-6 | Details |
| Methyl isonicotinate | C7H7NO2 | 2459-09-8 | Details |
| Efinaconazole Impurity 41 | C14H16F2O3 | 127001-03-0 | Details |
| Apalutamide Impurity 6 | Details |
| Apalutamide Impurity F | Details |
| N-nitroso-mirabegron | Details |
| Propyl 2-bromo-2-methylpropionate | C7H13BrO2 | 52890-69-4 | Details |
| Apalutamide Impurity 2 | C21H15F4N5O3 | 1332391-92-0 | Details |
| Atorvastatin Impurity 4 | C26H25NO3 | 444577-70-2 | Details |
| Fluticasone Impurity 1 | C26H28F2O7 | 397864-63-0 | Details |
| Desloratadine Impurity 3 | C19H19ClN2 | 1346600-61-0 | Details |
| 7-Bromo-2,4-dichloropyrido[3,2-d]pyrimidine | C7H2BrCl2N3 | 1215074-41-1 | Details |
| 2,6-dichloro-4-nitrobenzoic acid | C7H3Cl2NO4 | 22509-50-8 | Details |
| N-CYANOACETYLURETHANE | C6H8N2O3 | 6629-04-5 | Details |
| 2,2',3,3'-Tetramethylbiphenyl | 7495-46-7 | Details |
| Polymyxin B3 | C55H96N16O13 | 71140-58-4 | Details |
| Polymyxin B2 | C55H96N16O13 | 34503-87-2 | Details |
| Celecoxib Impurity 29 | C17H14F3N3O4S | 2247197-65-3 | Details |
| Risedronate EP Impurity C | C7H11NO7P2 | 105462-25-7 | Details |
| Epalrestat (E,E)-Isomer | C15H13NO3S2 | 863988-85-6 | Details |
| Valsartan Impurity 104 | C18H19NO2 | 2459446-56-9 | Details |
| 3-HYDROXY-4-METHOXYPHENETHYLAMINE HYDROCHLORIDE | C9H14ClNO2 | 645-33-0 | Details |
| Pantoprazole Impurity 11 DiHCl | C7H9ClF2N2O | 97963-77-4 | Details |
| 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile | C7H10N2O2S | 1187595-85-2 | Details |
| trans-4-[[(2-AMino-3,5-dibroMophenyl)Methylene]aMino]cyclohexanol | C13H16Br2N2O | 50910-53-7 | Details |
| 2-[1-(Mercaptomethyl)cyclopropyl]acetic acid | C6H10O2S | 162515-68-6 | Details |
| bortezoMib iMpurity F | Details |
| NA | Details |
| 1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanol | C12H18O5S | 2055542-18-0 | Details |
| S-(-)-EtoMidate | C14H16N2O2 | 56649-47-9 | Details |
| (R)-ethyl N-formyl-N-(1-phenylethyl)glycine | C13H17NO3 | 66514-85-0 | Details |
| SE 563 | C22H17ClF3NO3 | 174819-21-7 | Details |
| Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline) | C13H9ClF3N | 391860-73-4 | Details |
| rac 6-Chloro-1,4-dihydro-4-(1-pentynyl)-4-(trifluoroMethyl)-2H-3,1- benzoxazin-2-one | C14H11ClF3NO2 | 205755-86-8 | Details |
| rac Methyl Efavirenz | C15H11ClF3NO2 | 353270-76-5 | Details |
| P-[[(1S)-2-(6-AMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-phosphonic Acid Monoethyl Ester | C11H18N5O4P | 255525-18-8 | Details |
| 1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine | C12H13FN2 | 1610043-62-3 | Details |
| Cilnidipine Impurity 2 | C27H26N2O7 | 146845-34-3 | Details |
| VERAPAMIL RELATED COMPOUND D (50 MG) (5,5'-[[2-(3,4)DIMETHOXYPHENYL)ETHYL]IMINO]BIS[2-(3,4-DIMETHOXYPHENYL)-2-(1-METHYLETHYL)PENTANENI-TRILE] HYDROCHLORIDE) | C42H58ClN3O6 | 190850-50-1 | Details |
| Ceftazidime Ep Impurity H | C23H24N6O7S2 | 1354396-23-8 | Details |
| Verapamil | C27H38N2O4 | 52-53-9 | Details |
| (S)-1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol | C13H11ClF3NO | 209414-27-7 | Details |
| Ceftazidime EP Impurity E | C26H30N6O7S2 | 102772-66-7 | Details |
| Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride) | C17H27ClN2O2 | 67775-97-7 | Details |
| Cilnidipine Impurity 3 | C24H22N2O6 | 123853-41-8 | Details |
| 2-Acetyl-6-methoxynaphthalene | C13H12O2 | 3900-45-6 | Details |
| N-Acetyl-L-leucine | C8H15NO3 | 1188-21-2 | Details |
| Pregnenolone isobutyrate | C25H38O3 | Details |
| DEC-POC PMPA | C24H37N6O13P | 2820170-87-2 | Details |
| Apixaban Impurity 21 | C15H21N3O2 | 2435783-75-6 | Details |
| 4,7-dibromobenzo[b]thiophene | C8H4Br2S | 1391908-40-9 | Details |
| 4-amino-1-[(2R,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one | C8H11N3O3S | 131086-22-1 | Details |
| LZ100674 | C8H11NO3 | 2288740-67-8 | Details |
| NA | Details |
| Polymyxin B1 | C56H98N16O13 | 4135-11-9 | Details |
| Polymyxin B1-I | C56H98N16O13 | 811435-10-6 | Details |
| Apalutamide Impurity 5 | Details |
| 5,6-trans-Vitamin D3 | C27H44O | 22350-41-0 | Details |
| Product Total： Product Page： | ||||
| 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 | ||||